Safety of Perioperative Aspirin Therapy in Minimally Invasive Endometrial Cancer Staging

Giorgio Bogani, Antonella Cromi, Stefano Uccella, Maurizio Serati, Jvan Casarin, Ciro Pinelli, Fabio Ghezzi

Research output: Contribution to journalArticlepeer-review

Abstract

Study Objective: To investigate if low-dose aspirin influences the risk of bleeding and hemorrhagic complications during minimally invasive surgical staging for endometrial cancer. Design: Retrospective study (Canadian Task Force classification II-2.). Setting: University teaching hospital. Patients: Three hundred seventeen endometrial cancer patients undergoing laparoscopic staging. Interventions: Laparoscopic surgical staging included total laparoscopic hysterectomy plus bilateral salpingo-oophorectomy ± retroperitoneal staging. Measurement and Main Results: Forty-three (14%) low-dose aspirin users were compared with 274 (86%) nonaspirin users. Aspirin-treated patients were older than patients in the control group (71 [range, 50-85] vs 64 [range, 27-92] years old, p

Original languageEnglish
Pages (from-to)636-641
Number of pages6
JournalJournal of Minimally Invasive Gynecology
Volume21
Issue number4
DOIs
Publication statusPublished - 2014

Keywords

  • Antiplatelet therapy
  • Aspirin
  • Endometrial cancer
  • Laparoscopy
  • Lymphadenectomy

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Medicine(all)

Fingerprint

Dive into the research topics of 'Safety of Perioperative Aspirin Therapy in Minimally Invasive Endometrial Cancer Staging'. Together they form a unique fingerprint.

Cite this